Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders
- PMID: 17910603
- DOI: 10.1111/j.1600-079X.2007.00485.x
Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders
Abstract
To date, there have been no prospective long-term studies of melatonin therapy in children. We report here data from a prospective follow-up study of 44 children with neurodevelopmental disabilities and treatment-resistant circadian rhythm sleep disorders (CRSD) who had participated in a placebo controlled, double blind cross-over trial of sustained-release melatonin. The follow-up study involved a structured telephone interview of caregivers every 3 months for upto 3.8 yr. The caregivers provided ratings of satisfaction, adverse effects, benefits, persistence with treatment and additional medications. Changes in melatonin dose were recorded. Open ended questions were included to capture caregivers' impressions and comments concerning melatonin therapy. Adverse reaction to melatonin therapy and development of tolerance were not evident. Better sleep was associated with reported improvement in health, behavior and learning. At the end of the study, the parental comments regarding the effectiveness of long-term melatonin therapy were highly positive. Parents whose children had sleep maintenance difficulties expressed a wish to have a commercially available controlled-release melatonin product which would promote sleep for 8-10 hr. Hypnotics for children with CRSD should be considered a second line of treatment for those who fail to respond to sleep hygiene and/or melatonin.
Similar articles
-
Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia.J Pineal Res. 2009 Aug;47(1):1-7. doi: 10.1111/j.1600-079X.2009.00681.x. Epub 2009 May 27. J Pineal Res. 2009. PMID: 19486273
-
A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.J Pineal Res. 2008 Jan;44(1):57-64. doi: 10.1111/j.1600-079X.2007.00528.x. J Pineal Res. 2008. PMID: 18078449 Clinical Trial.
-
Melatonin and sleep disorders associated with intellectual disability: a clinical review.J Intellect Disabil Res. 2007 Jan;51(Pt 1):2-13. doi: 10.1111/j.1365-2788.2006.00893.x. J Intellect Disabil Res. 2007. PMID: 17181598 Review.
-
Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.Brain Dev. 2004 Sep;26(6):373-6. doi: 10.1016/S0387-7604(03)00197-9. Brain Dev. 2004. PMID: 15275698 Clinical Trial.
-
[Melatonin treatment of sleep disorders in disabled children].Tidsskr Nor Laegeforen. 2002 Apr 20;122(10):1009-11. Tidsskr Nor Laegeforen. 2002. PMID: 12082692 Review. Norwegian.
Cited by
-
Adherence to treatment and parents' perspective about effectiveness of melatonin in children with autism spectrum disorder and sleep disturbances.Child Adolesc Psychiatry Ment Health. 2023 Oct 27;17(1):123. doi: 10.1186/s13034-023-00669-w. Child Adolesc Psychiatry Ment Health. 2023. PMID: 37891596 Free PMC article.
-
The short-term and long-term adverse effects of melatonin treatment in children and adolescents: a systematic review and GRADE assessment.EClinicalMedicine. 2023 Jul 6;61:102083. doi: 10.1016/j.eclinm.2023.102083. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37483551 Free PMC article.
-
Delayed sleep-wake phase disorder and its related sleep behaviors in the young generation.Front Psychiatry. 2023 May 19;14:1174719. doi: 10.3389/fpsyt.2023.1174719. eCollection 2023. Front Psychiatry. 2023. PMID: 37275982 Free PMC article. Review.
-
Chronic Administration of Melatonin: Physiological and Clinical Considerations.Neurol Int. 2023 Mar 15;15(1):518-533. doi: 10.3390/neurolint15010031. Neurol Int. 2023. PMID: 36976674 Free PMC article. Review.
-
Discrete-time Survival Analysis of Risk Factors for Early Menarche in Korean Schoolgirls.J Prev Med Public Health. 2023 Jan;56(1):59-66. doi: 10.3961/jpmph.22.428. Epub 2022 Dec 29. J Prev Med Public Health. 2023. PMID: 36746423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources